Molecular Reagent HemeScreen® WT1 For Research Use Only For HRM-enabled RT-PCR Machine / Cytopenia Panel 100 Tests

Features

• Precipio’s HemeScreen® offerings are Research Use Only (RUO) assays that screen for clinically actionable somatic mutations in targets of interest related to myeloproliferative disorders and haematological cancers
• The reagents are designed to be used in a clinical diagnostic laboratory by suitably trained personnel testing DNA extracted from whole blood or bone marrow using a PCR-based method and High Resolution Melt (HRM) Analysis
• WT1 (Wilms’ Tumor 1) can lead to higher relapse rate and poor prognosis in patients with acute myeloid leukemia (AML)
• WT1 mutations may be observed in 6-15% of AML cases, often with patients who have FLT3-ITD and/or CEBPA mutations
• WT1 mutations can be used as a tool in determining MRD
• Free-Flow Reagent
• Each HemeScreen® reagent sets contains enough reactions for 100 samples in duplicate and includes enough Mutant control for 5 reactions
• Machine required HRM-enabled RT-PCR (example/ ThermoFisher Quantstudio 3 or higher)
• Reagent sets should be stored in the dark between -18 °C and -25 °C in a constant temperature freezer until use

More Information

• SDS